BEAM
Price
$25.98
Change
+$0.19 (+0.74%)
Updated
Oct 17 closing price
Capitalization
2.63B
21 days until earnings call
Intraday Buy/Sell Signals
OCGN
Price
$1.60
Change
-$0.01 (-0.62%)
Updated
Oct 17 closing price
Capitalization
499.69M
18 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

BEAM vs OCGN

Header iconBEAM vs OCGN Comparison
Open Charts BEAM vs OCGNBanner chart's image
Beam Therapeutics
Price$25.98
Change+$0.19 (+0.74%)
Volume$1.99M
Capitalization2.63B
Ocugen
Price$1.60
Change-$0.01 (-0.62%)
Volume$4.3M
Capitalization499.69M
BEAM vs OCGN Comparison Chart in %
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. OCGN commentary
Oct 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and OCGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 20, 2025
Stock price -- (BEAM: $25.98 vs. OCGN: $1.60)
Brand notoriety: BEAM and OCGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 74% vs. OCGN: 85%
Market capitalization -- BEAM: $2.63B vs. OCGN: $499.69M
BEAM [@Biotechnology] is valued at $2.63B. OCGN’s [@Biotechnology] market capitalization is $499.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileOCGN’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • OCGN’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than OCGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 3 TA indicator(s) are bullish while OCGN’s TA Score has 2 bullish TA indicator(s).

  • BEAM’s TA Score: 3 bullish, 5 bearish.
  • OCGN’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than OCGN.

Price Growth

BEAM (@Biotechnology) experienced а -1.29% price change this week, while OCGN (@Biotechnology) price change was -6.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

OCGN is expected to report earnings on Nov 07, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.63B) has a higher market cap than OCGN($500M). OCGN YTD gains are higher at: 98.758 vs. BEAM (4.758). OCGN has higher annual earnings (EBITDA): -52.34M vs. BEAM (-414.33M). BEAM has more cash in the bank: 1.15B vs. OCGN (27M). OCGN has less debt than BEAM: OCGN (32.8M) vs BEAM (155M). BEAM has higher revenues than OCGN: BEAM (60.3M) vs OCGN (4.75M).
BEAMOCGNBEAM / OCGN
Capitalization2.63B500M526%
EBITDA-414.33M-52.34M792%
Gain YTD4.75898.7585%
P/E RatioN/AN/A-
Revenue60.3M4.75M1,268%
Total Cash1.15B27M4,259%
Total Debt155M32.8M473%
FUNDAMENTALS RATINGS
OCGN: Fundamental Ratings
OCGN
OUTLOOK RATING
1..100
81
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
PROFIT vs RISK RATING
1..100
90
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMOCGN
RSI
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
84%
Momentum
ODDS (%)
N/A
Bearish Trend 3 days ago
86%
MACD
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 5 days ago
81%
Declines
ODDS (%)
Bearish Trend 7 days ago
84%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
72%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IBCGX14.160.08
+0.57%
VY® Baron Growth S2
UIGRX44.460.13
+0.29%
Victory Growth Institutional
SFDYX31.940.05
+0.16%
SEI Mid-Cap Y (SIMT)
GTORX43.180.07
+0.16%
Goldman Sachs Technology Opps R6
CCIZX199.83-0.97
-0.48%
Columbia Seligman Tech & Info Inst

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+0.74%
CRSP - BEAM
66%
Closely correlated
+1.05%
NTLA - BEAM
64%
Loosely correlated
-0.64%
RXRX - BEAM
62%
Loosely correlated
-7.86%
AXON - BEAM
57%
Loosely correlated
+2.84%
PRME - BEAM
56%
Loosely correlated
-6.03%
More

OCGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCGN has been loosely correlated with RAIN. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if OCGN jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCGN
1D Price
Change %
OCGN100%
-0.62%
RAIN - OCGN
53%
Loosely correlated
-0.80%
ARRY - OCGN
47%
Loosely correlated
-0.17%
AXON - OCGN
46%
Loosely correlated
+2.84%
IPSC - OCGN
45%
Loosely correlated
-2.60%
NTLA - OCGN
42%
Loosely correlated
-0.64%
More